Creating New Enzyme Actions De Novo

Abstract Enzymes are molecules, especially proteins that catalyze chemical reactions. As with all catalysts, enzymes accelerate the reaction rate by reducing activation energy. Nucleic acid RNA molecules called ribozymes also act as enzymes and can catalyze reactions. The development of new enzymes for synthesizing chemical reaction, pharmaceutical and molecular biology tools is a new and future concern. Research to improve and improve existing enzymes under development has been done before.

Figure 3. Recombinant pathway for scorpionisation mobilization by metabolic and de novo synthesis and repair synthase, PRPP amidase, and hypoxanthine phosphorylated cellulose transferase (HPRT) and adenine phosphoryltransferase (APRT). HPRT catalyzes the salvation of inosine monophosphate, IMP and guanosine monophosphate GMP from hypoxanthine and guanine, in particular by using PRPP as co-substrate. The absence of HPRT leads to the degradation of hypoxanthine and guanine, which is converted to uric acid by xanthine oxidase. This results in excessive production of sputum, elevated PRPP levels and a reduction in IMP and GMP levels (Torres R J and Puig J G, 2007).

The first to last path begins with a ribose active form from ribose-5-phosphate to 5-phosphate ribose-1-pyrophosphate (PRPP), which synthesizes AMP. PRPP produces the first nucleotide called inosine monophosphate (IMP) by the enzyme PRPP aminotransferase. This serves as the rate limiting stage. In addition, IMP has been used as a pioneer in the synthesis of AMP and GMP and the pathway is regulated by higher levels of specific nucleotides (Fox, I. H and Kelley, W. N, 1971). There are two major transferases involved in the treatment of sputum. HPRT is the adenosine phosphoribosyltransferase (APRT) which catalyzes the catalysis of hypoxanthine from inosine monophosphate (IMP) and guanine to guanosine monophosphate (GMP) and the other through 5-phosphate ribose-1 . - Pyrophosphate transfer of 5-phosphate ribose group assembles adenine to AMP (PRPP) (Keebaugh et al., 2007).